UK company record
Beacon Therapeutics
Gene therapy (ophthalmology)
VerifiedCore UK
Snapshot
- UK location
- London (dual HQ with Cambridge, Massachusetts, US - verify UK-HQ eligibility before use) · London
- Sector
- Biotech & techbio
- Latest recorded round
- Series B
- Latest recorded amount
- $170M
- Date
- 2024-07-01
Legal-identity layer
Verified identity.
- Selected legal name
- BEACON THERAPEUTICS LIMITED
- Company number
- 14426488
- Companies House status
- active
- Incorporated
- 2022-10-18
Investors
- Advent Life SciencesParticipant
- ForbionLead
- Oxford Science EnterprisesParticipant
- SynconaParticipant
- TCGXParticipant
- University of OxfordParticipant
Current directors and active controllers
- BALDO, LanceCurrent director
- Beacon Therapeutics Holdings LimitedActive controller
- RIGBY, Benjamin ThomasCurrent director
- FELLOWS, David Andrewdirector
- HOLLOWOOD, Christopher John, Drdirector
- PETRIS, Elisa Michela, Drdirector
Funding rows
- Series B$170M · 2024-07-01